WorkBoat Header Background Image

WorkBoat+ Membership – Free to Join

Thank you for another great WorkBoat Show! We hope to see everyone back in New Orleans December 2–4, 2026. Save the date!

Workboat Indexes

Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Workboat Indexes
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc. Common Stock (NY:BHC)

7.220 +0.040 (+0.56%)
Streaming Delayed Price Updated: 9:48 AM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Bausch Health Announces Second Quarter 2025 Results
Via ACCESS Newswire
News headline image
Earnings Scheduled For July 30, 2025 ↗
 
Via Benzinga
News headline image
Bausch Health Companies's Earnings Outlook ↗
 
Via Benzinga
News headline image
Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout ↗
Bausch Health will acquire DURECT and larsucosterol, aiming for FDA approval of a first treatment for alcoholic hepatitis via Phase 3 trials. 
Via Benzinga
News headline image
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
Via ACCESS Newswire
News headline image
Bausch Health to Reduce Debt by Approximately $900 Million Using Cash On Hand
Via ACCESS Newswire
News headline image
Earnings Scheduled For April 30, 2025 ↗
 
Via Benzinga
News headline image
Bausch Health Announces the Appointment of Two New Members to Its Board of Directors
Via ACCESS Newswire
News headline image
Bausch Health Appoints New Chief Accounting Officer
Via ACCESS Newswire
News headline image
Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence
Via ACCESS Newswire
News headline image
Bausch Health to Announce Second Quarter 2025 Results on July 30
Via ACCESS Newswire
News headline image
GMS Posts Upbeat Earnings, Joins Coinbase Global, Genworth Financial, Sandisk And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Oklo, Quantum Computing And Transocean Are Among Top 10 Mid Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio? ↗
Top mid-cap stocks gain, led by energy companies due to increased oil prices from Middle East conflict. Oklo, Bausch Health, Quantum Computing among top performers. 
Via Benzinga
News headline image
The Smart Money Is Buying These 10 Stocks ↗
 
Via Benzinga
News headline image
Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90% ↗
Carl Icahn boosts holdings in Illumina and JetBlue, showing confidence in biotech and airlines. He also trims exposure to Southwest Gas Holdings. 
Via Benzinga
News headline image
Bausch Health Announces 2025 Annual Meeting of Shareholder Results
Via ACCESS Newswire
News headline image
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization
Via ACCESS Newswire
News headline image
Bausch Health Announces First Quarter 2025 Results
Via ACCESS Newswire
News headline image
Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System
Via ACCESS Newswire
News headline image
Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM)
Via ACCESS Newswire
News headline image
Bausch Health Says Carl Icahn Has 34% Economic Interest In Its Outstanding Shares ↗
This disclosure comes days after the company announced a new “poison pill” plan to safeguard shareholders’ rights and prevent hostile takeovers. 
Via Stocktwits
News headline image
Bausch Health Announces Filing of Supplement to Proxy Statement
Via ACCESS Newswire
News headline image
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
Via ACCESS Newswire
News headline image
Bausch Health Announces Adoption of Shareholder Rights Plan
Via ACCESS Newswire
News headline image
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
Via ACCESS Newswire
News headline image
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Via ACCESS Newswire
News headline image
Bausch Health to Announce First Quarter Results on April 30
Via ACCESS Newswire
News headline image
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes
Via ACCESS Newswire
News headline image
Bausch Health Announces Conditional Redemption of Senior Notes
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Privacy Policy DSAR Requests Terms of Use Locations Events, Products & Services
© 2025 Diversified Communications. All rights reserved.